Global Bioresorbable Polymers Market Size Study, by Type (Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polylactic-co-glycolic acid (PLGA), Polycaprolactone (PCL)), Application (Orthopedic Devices, Drug Delivery), and Regional Forecasts 2022-2032

Description

The global bioresorbable polymers market, valued at approximately USD 0.44 billion in 2023, is projected to grow significantly at a compound annual growth rate (CAGR) of 11.60%, reaching USD 1.18 billion by 2032. Bioresorbable polymers have emerged as a transformative solution in medical applications, particularly in orthopedic devices and drug delivery systems. These polymers are designed to degrade safely within the body, eliminating the need for surgical removal and reducing post-procedure complications, thereby making them a critical component in advancing healthcare technologies.

The growing adoption of bioresorbable polymers in orthopedic surgeries is one of the key drivers of market expansion. As minimally invasive procedures gain traction globally, the need for advanced, biocompatible, and degradable materials has risen exponentially. The integration of polylactic-co-glycolic acid (PLGA) in drug delivery systems, owing to its controlled degradation and drug release properties, is further propelling market growth. Moreover, technological advancements in polymer synthesis and manufacturing have enabled the development of high-performance materials that cater to complex medical requirements. However, the market faces challenges such as high production costs and the technical expertise required for their development and application.

Regionally, North America dominates the bioresorbable polymers market due to advanced healthcare infrastructure and significant investment in R&D activities. Europe follows closely, driven by stringent regulatory frameworks promoting biocompatible materials. Meanwhile, the Asia-Pacific region is expected to witness the fastest growth during the forecast period, spurred by increasing healthcare expenditure, rising medical tourism, and expanding pharmaceutical and biomedical industries in countries like China and India.

Major market players included in this report are:

BASF SE
Corbion N.V.
Evonik Industries AG
Poly-Med, Inc.
Foster Corporation
KLS Martin Group
Purac Biomaterials
Ashland Global Holdings Inc.
DSM Biomedical
Sigma-Aldrich Corporation
NatureWorks LLC
Tepha Inc.
Toray Industries
Bezwada Biomedical, LLC
SEKISUI CHEMICAL CO., LTD.

The detailed segments and sub-segment of the market are explained below:

By Type:

Polylactic Acid (PLA)
Polyglycolic Acid (PGA)
Polylactic-co-glycolic acid (PLGA)
Polycaprolactone (PCL)

By Application:

Orthopedic Devices
Drug Delivery

By Region:

North America:

U.S.
Canada

Europe:

UK
Germany
France
Spain
Italy
Rest of Europe

Asia-Pacific:

China
India
Japan
Australia
South Korea
Rest of Asia-Pacific

Latin America:

Brazil
Mexico

Middle East & Africa:

Saudi Arabia
South Africa
Rest of Middle East & Africa

Key Takeaways:

Comprehensive market estimates and forecasts for a decade (2022-2032).
Detailed insights into regional and segment-level dynamics.
In-depth competitive analysis of major players and their strategies.
Exploration of market drivers, challenges, and opportunities.
Strategic recommendations to capitalize on emerging trends and maximize market potential.

Chapter 1. Global Bioresorbable Polymers Market Executive Summary

1.1. Global Bioresorbable Polymers Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Type
- 1.3.2. By Application
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Bioresorbable Polymers Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory Frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Bioresorbable Polymers Market Dynamics

3.1. Market Drivers
- 3.1.1. Rising Adoption in Orthopedic Surgeries
- 3.1.2. Increasing Demand in Drug Delivery Systems
- 3.1.3. Technological Advancements in Polymer Synthesis
3.2. Market Challenges
- 3.2.1. High Production Costs
- 3.2.2. Limited Availability of Skilled Professionals
3.3. Market Opportunities
- 3.3.1. Expansion into Emerging Markets
- 3.3.2. Development of Advanced Bioresorbable Materials
- 3.3.3. Integration with Smart Manufacturing Solutions

Chapter 4. Global Bioresorbable Polymers Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Bioresorbable Polymers Market Size & Forecasts by Type 2022-2032

5.1. Segment Dashboard
5.2. Global Bioresorbable Polymers Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 5.2.1. Polylactic Acid (PLA)
- 5.2.2. Polyglycolic Acid (PGA)
- 5.2.3. Polylactic-co-glycolic Acid (PLGA)
- 5.2.4. Polycaprolactone (PCL)

Chapter 6. Global Bioresorbable Polymers Market Size & Forecasts by Application 2022-2032

6.1. Segment Dashboard
6.2. Global Bioresorbable Polymers Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 6.2.1. Orthopedic Devices
- 6.2.2. Drug Delivery

Chapter 7. Global Bioresorbable Polymers Market Size & Forecasts by Region 2022-2032

7.1. North America Bioresorbable Polymers Market
- 7.1.1. U.S. Bioresorbable Polymers Market
  - 7.1.1.1. Type Breakdown Size & Forecasts, 2022-2032
  - 7.1.1.2. Application Breakdown Size & Forecasts, 2022-2032
- 7.1.2. Canada Bioresorbable Polymers Market
  - 7.1.2.1. Type Breakdown Size & Forecasts, 2022-2032
  - 7.1.2.2. Application Breakdown Size & Forecasts, 2022-2032
7.2. Europe Bioresorbable Polymers Market
- 7.2.1. UK Bioresorbable Polymers Market
  - 7.2.1.1. Type Breakdown Size & Forecasts, 2022-2032
  - 7.2.1.2. Application Breakdown Size & Forecasts, 2022-2032
- 7.2.2. Germany Bioresorbable Polymers Market
  - 7.2.2.1. Type Breakdown Size & Forecasts, 2022-2032
  - 7.2.2.2. Application Breakdown Size & Forecasts, 2022-2032
- 7.2.3. France Bioresorbable Polymers Market
  - 7.2.3.1. Type Breakdown Size & Forecasts, 2022-2032
  - 7.2.3.2. Application Breakdown Size & Forecasts, 2022-2032
- 7.2.4. Spain Bioresorbable Polymers Market
  - 7.2.4.1. Type Breakdown Size & Forecasts, 2022-2032
  - 7.2.4.2. Application Breakdown Size & Forecasts, 2022-2032
- 7.2.5. Italy Bioresorbable Polymers Market
  - 7.2.5.1. Type Breakdown Size & Forecasts, 2022-2032
  - 7.2.5.2. Application Breakdown Size & Forecasts, 2022-2032
- 7.2.6. Rest of Europe Bioresorbable Polymers Market
  - 7.2.6.1. Type Breakdown Size & Forecasts, 2022-2032
  - 7.2.6.2. Application Breakdown Size & Forecasts, 2022-2032
7.3. Asia-Pacific Bioresorbable Polymers Market
- 7.3.1. China Bioresorbable Polymers Market
  - 7.3.1.1. Type Breakdown Size & Forecasts, 2022-2032
  - 7.3.1.2. Application Breakdown Size & Forecasts, 2022-2032
- 7.3.2. India Bioresorbable Polymers Market
  - 7.3.2.1. Type Breakdown Size & Forecasts, 2022-2032
  - 7.3.2.2. Application Breakdown Size & Forecasts, 2022-2032
- 7.3.3. Japan Bioresorbable Polymers Market
  - 7.3.3.1. Type Breakdown Size & Forecasts, 2022-2032
  - 7.3.3.2. Application Breakdown Size & Forecasts, 2022-2032
- 7.3.4. Australia Bioresorbable Polymers Market
  - 7.3.4.1. Type Breakdown Size & Forecasts, 2022-2032
  - 7.3.4.2. Application Breakdown Size & Forecasts, 2022-2032
- 7.3.5. South Korea Bioresorbable Polymers Market
  - 7.3.5.1. Type Breakdown Size & Forecasts, 2022-2032
  - 7.3.5.2. Application Breakdown Size & Forecasts, 2022-2032
- 7.3.6. Rest of Asia-Pacific Bioresorbable Polymers Market
  - 7.3.6.1. Type Breakdown Size & Forecasts, 2022-2032
  - 7.3.6.2. Application Breakdown Size & Forecasts, 2022-2032
7.4. Latin America Bioresorbable Polymers Market
- 7.4.1. Brazil Bioresorbable Polymers Market
  - 7.4.1.1. Type Breakdown Size & Forecasts, 2022-2032
  - 7.4.1.2. Application Breakdown Size & Forecasts, 2022-2032
- 7.4.2. Mexico Bioresorbable Polymers Market
  - 7.4.2.1. Type Breakdown Size & Forecasts, 2022-2032
  - 7.4.2.2. Application Breakdown Size & Forecasts, 2022-2032
- 7.4.3. Rest of Latin America Bioresorbable Polymers Market
  - 7.4.3.1. Type Breakdown Size & Forecasts, 2022-2032
  - 7.4.3.2. Application Breakdown Size & Forecasts, 2022-2032
7.5. Middle East & Africa Bioresorbable Polymers Market
- 7.5.1. Saudi Arabia Bioresorbable Polymers Market
  - 7.5.1.1. Type Breakdown Size & Forecasts, 2022-2032
  - 7.5.1.2. Application Breakdown Size & Forecasts, 2022-2032
- 7.5.2. South Africa Bioresorbable Polymers Market
  - 7.5.2.1. Type Breakdown Size & Forecasts, 2022-2032
  - 7.5.2.2. Application Breakdown Size & Forecasts, 2022-2032
- 7.5.3. Rest of Middle East & Africa Bioresorbable Polymers Market
  - 7.5.3.1. Type Breakdown Size & Forecasts, 2022-2032
  - 7.5.3.2. Application Breakdown Size & Forecasts, 2022-2032

Chapter 8. Competitive Intelligence

8.1. Key Company SWOT Analysis
- 8.1.1. BASF SE
- 8.1.2. Corbion N.V.
- 8.1.3. Evonik Industries AG
8.2. Top Market Strategies
8.3. Company Profiles
- 8.3.1. BASF SE
  - 8.3.1.1. Key Information
  - 8.3.1.2. Overview
  - 8.3.1.3. Financial (Subject to Data Availability)
  - 8.3.1.4. Product Summary
  - 8.3.1.5. Market Strategies
- 8.3.2. Corbion N.V.
- 8.3.3. Evonik Industries AG
- 8.3.4. Poly-Med, Inc.
- 8.3.5. Foster Corporation
- 8.3.6. KLS Martin Group
- 8.3.7. Purac Biomaterials
- 8.3.8. Ashland Global Holdings Inc.
- 8.3.9. DSM Biomedical
- 8.3.10. Sigma-Aldrich Corporation

Chapter 9. Research Process

9.1. Research Process
- 9.1.1. Data Mining
- 9.1.2. Analysis
- &; 9.1.3. Market Estimation
- 9.1.4. Validation
- 9.1.5. Publishing
9.2. Research Attributes